Cantor Fitzgerald Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VWM
Cantor Fitzgerald Investment Advisors's PFE Position: Q3 2026 in Review
Cantor Fitzgerald Investment Advisors increased its Pfizer (PFE) stake by 0.91% in Q3 2026, buying an estimated $120K and bringing the position to 501,592 shares worth $14.3M. The position accounts for 0.98% of the portfolio, ranked #38.
Cantor Fitzgerald Investment Advisors first reported a position in PFE in Q2 2021 and has held it in 16 quarters since. The position peaked at $25.3M in Q1 2022. 415 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Cantor Fitzgerald Investment Advisors held 501,592 shares of Pfizer worth $14.3M as of Q3 2026.
- Cantor Fitzgerald Investment Advisors bought 4,509 Pfizer shares in Q3 2026, an estimated $120K.
- Pfizer made up 0.98% of Cantor Fitzgerald Investment Advisors's portfolio in Q3 2026, its #38 holding.
- Cantor Fitzgerald Investment Advisors first reported a position in Pfizer in Q2 2021 and has held it in 16 quarters since.
- Cantor Fitzgerald Investment Advisors's Pfizer position peaked at $25.3M in Q1 2022.
- 415 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.